Daniel, Justin Kirby .

HRN: 22-63-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/01/2024
03/07/2024
IV
585mg
Q6h
Pcap
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: